Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
Abstract Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels in malignant tumours. uPAR is closely related to the invasion and metastasis of malignant tumours, plays impo...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Revisão |
| Sprache: | Englisch |
| Veröffentlicht: |
2022
|
| Online-Zugang: | https://doi.org/10.1186/s12967-022-03329-3 https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-022-03329-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!